Skip to content

Clinical trials

Completed Fallopian Tube Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Completed Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20063
20093
20102
20121
20132
20141
20162
20171
20181
20191
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
AbbVie2
MEI Pharma, Inc.2
Novartis Pharmaceuticals2
pharmaand GmbH2
Bristol-Myers Squibb1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms25
Ovarian Neoplasms20
Carcinoma, Ovarian Epithelial14
Peritoneal Neoplasms6
Neoplasms3
Carcinoma2
Recurrence2
Anus Neoplasms1
Bile Duct Neoplasms1
Brenner Tumor1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.